Accessibility Menu
ProMIS Neurosciences logo

ProMIS Neurosciences

(NASDAQ) PMN

Current Price$10.53
Market Cap$22.06M
Since IPO (2012)-98%
5 Year-96%
1 Year-13%
1 Month+1%

ProMIS Neurosciences Financials at a Glance

Market Cap

$22.06M

Revenue (TTM)

$0.00

Net Income (TTM)

-$40.62M

EPS (TTM)

-$19.41

P/E Ratio

-0.53

Dividend

$0.00

Beta (Volatility)

0.55 (Low)

Price

$10.53

Volume

4,557

Open

$10.41

Previous Close

$10.53

Daily Range

$10.38 - $10.66

52-Week Range

$6.27 - $39.75

Estimated Earnings Date

Aug 12, 2026

PMN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ProMIS Neurosciences

Industry

Biotechnology

Sector

Health Care

Employees

11

CEO

Neil K. Warma, MBA

Website

www.promisneurosciences.com

Headquarters

Toronto, ON M4S 3E2, CA

PMN Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-237.99%

Return on Capital

N/A

Return on Assets

-60.25%

Earnings Yield

-1.89%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$22.06M

Shares Outstanding

2.15M

Volume

4.56K

Avg. Volume

31.27K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$41.35M

EBITDA

-$41.02M

Operating Cash Flow

-$35.47M

Capital Expenditure

$0.00

Free Cash Flow

-$35.47M

Cash & ST Invst.

$63.85M

Total Debt

$0.00

ProMIS Neurosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$22.06M

N/A

Market Cap/Employee

$3.15M

N/A

Employees

7

N/A

Net Income

-$8.24M

-12.2%

EBITDA

-$8.64M

-17.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$63.85M

+660.3%

Total Debt

$0.00

N/A

Accounts Receivable

$238.33K

+336.8%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-60.25%

N/A

Return on Invested Capital

-68.02%

N/A

Free Cash Flow

-$12.38M

-151.3%

Operating Cash Flow

-$12.38M

-151.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MPLTMapLight Therapeutics, Inc.
$33.28+4.13%
LPCNLipocine Inc.
$2.46+3.36%
OSRHOSR Holdings, Inc.
$0.33+4.18%
BRTXBioRestorative Therapies, Inc.
$0.37-6.19%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.87+0.02%
KEELKeel Infrastructure
$6.03+0.03%
SOFISoFi Technologies
$17.88+0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.67+0.04%

Questions About PMN

What is the current price of ProMIS Neurosciences?

ProMIS Neurosciences is trading at $10.53 per share.

What is the 52-week range for ProMIS Neurosciences?

Over the past 52 weeks, ProMIS Neurosciences has traded between $6.27 and $39.75.

How much debt does ProMIS Neurosciences have?

As of the most recent reporting period, ProMIS Neurosciences reported total debt of $0.00.

How much cash does ProMIS Neurosciences have on hand?

ProMIS Neurosciences reported $63.81M in cash and cash equivalents in its most recent financial results.

What is ProMIS Neurosciences’s dividend yield?

ProMIS Neurosciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services